Literature DB >> 1728489

Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Relation to regional blood flow and glucose uptake.

J L Vanoverschelde1, J A Melin, A Bol, R Vanbutsele, M Cogneau, D Labar, A Robert, C Michel, W Wijns.   

Abstract

BACKGROUND: Enhanced uptake of the glucose analogue 18F-fluorodeoxyglucose (FDG) in relation to flow has been proposed as an accurate method of identifying viable myocardium. The evaluation of myocardial oxidative metabolism could be an alternate way to identify reversible injury. The aim of the present study was to investigate in patients with reperfused anterior infarction whether differences in regional oxidative metabolism exist among regions with and without flow-metabolism mismatch. METHODS AND
RESULTS: Fifteen patients with reperfused anterior myocardial infarction were studied between 2 weeks and 3 months after the acute event. Regional myocardial blood flow (13N-ammonia; three-compartment model), oxidative metabolism (11C-acetate; monoexponential clearance), and glucose uptake (FDG, linear graphic analysis) were evaluated with dynamic positron emission tomography. Flow-metabolism patterns were used to differentiate reversibly (FDG/flow greater than 1.2) from irreversibly injured myocardium (FDG/flow less than 1.2) using circumferential profile technique. Relative 13N-ammonia uptake was reduced in 71 of 90 anterior and/or septal segments, including 24 with (seven patients) and 38 without (eight patients) flow-metabolism mismatch. Acetate clearance (k), reflecting oxidative metabolism, was reduced by 51% in the center of the infarct area versus remote segments (27 +/- 12 versus 55 +/- 13 min-1.10(-3), p less than 0.001). Compared with infarct segments without flow-metabolism mismatch, segments exhibiting increased glucose uptake relative to flow had faster acetate clearance (35 +/- 14 versus 23 +/- 9 min-1.10(-3), p less than 0.01). Similarly, myocardial blood flow was better preserved in segments with flow-metabolism mismatch (54 +/- 13 versus 45 +/- 8 ml/min/100 g, p less than 0.01) compared with segments without mismatch. However, at similar levels of hypoperfusion, there was no significant difference in acetate clearance among segments with and those without flow-metabolism mismatch: 37 +/- 14 versus 41 +/- 15 min-1.10(-3), respectively. A positive correlation (r = 0.89, p less than 0.001) was found between absolute myocardial blood flow and acetate clearance, regardless of the flow-metabolism pattern.
CONCLUSIONS: In patients with reperfused myocardial infarction studied between 2 weeks and 3 months after the acute event, regional oxidative metabolism is reduced in proportion to residual myocardial blood flow and does not differ significantly among similarly hypoperfused segments with and without flow-metabolism mismatch.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728489     DOI: 10.1161/01.cir.85.1.9

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

Review 1.  The value of quantitative myocardial perfusion imaging with positron emission tomography in coronary artery disease.

Authors:  W Wijns; P G Camici
Journal:  Herz       Date:  1997-04       Impact factor: 1.443

Review 2.  SPECT and PET to optimize cardiac stem cell therapy.

Authors:  Angel T Chan; M Roselle Abraham
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

Review 3.  [Examination of myocardial perfusion with positron emission tomography: a clinically useful and valid method?].

Authors:  J vom Dahl
Journal:  Herz       Date:  1997-02       Impact factor: 1.443

Review 4.  Comparison of approaches in the assessment of myocardial viability and follow-up of PTCA/CABG. The role of echocardiography.

Authors:  L A Piérard
Journal:  Int J Card Imaging       Date:  1993

5.  Reverse blood flow-glucose metabolism mismatch indicates preserved oxygen metabolism in patients with revascularised myocardial infarction.

Authors:  Yoshitomo Fukuoka; Akira Nakano; Hiroyasu Uzui; Naoki Amaya; Kentaro Ishida; Kenichiro Arakawa; Takashi Kudo; Hidehiko Okazawa; Takanori Ueda; Jong-Dae Lee; Hiroshi Tada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-27       Impact factor: 9.236

Review 6.  Imaging of metabolism and autonomic innervation of the heart by positron emission tomography.

Authors:  P Mélon; M Schwaiger
Journal:  Eur J Nucl Med       Date:  1992

7.  Incidence of hibernating myocardium after acute myocardial infarction treated with thrombolysis.

Authors:  J N Adams; M Norton; R J Trent; P Mikecz; S Walton; N Evans
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

Review 8.  Assessment of viability after myocardial infarction. Clinical relevance and methodological problems.

Authors:  G Fragasso; A Margonato; S L Chierchia
Journal:  Int J Card Imaging       Date:  1993

Review 9.  Assessment of left ventricular dysfunction by nuclear cardiology.

Authors:  J A Melin; W Wijns; J L Vanoverschelde; G R Heyndrickx
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

10.  Flow-function relationships in chronic left-ventricular ischemic dysfunction: Impact of the transmurality of infarction.

Authors:  Bernhard L Gerber; Ho Thien Thanh; Véronique Roelants; Agnès Pasquet; David Vancraeynest; Jean-Louis J Vanoverschelde
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.